Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
44.84
+5.97 (15.36%)
Nov 6, 2026, 1:10 PM EST - Market open
Edgewise Therapeutics Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Edgewise Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $54. The average 1-year stock price forecast is 20.43% higher than the current stock price, while the lowest is $36 (-19.71%) and the highest is $66 (+47.19%).
Price Target: $54 (+20.43%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Edgewise Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 8 | 8 | 8 | 9 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 13 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $51 | Buy | Maintains | $51 | +13.74% | Nov 6, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $55 | Buy | Maintains | $55 | +22.66% | Nov 5, 2026 |
| Raymond James | Raymond James | Buy Reiterates $66 → $85 | Buy | Reiterates | $66 → $85 | +89.56% | Nov 5, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Hold Reiterates $36 | Hold | Reiterates | $36 | -19.71% | Nov 5, 2026 |
| Wedbush | Wedbush | Buy Maintains $51 | Buy | Maintains | $51 | +13.74% | Nov 5, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
31.36M
EPS This Year
2.27
from -1.63
EPS Next Year
-1.87
from 2.27
EPS and Forward PE are based on non-GAAP adjusted numbers.